Tuesday, November 29, 2011

Odyssey Thera is First to Install Next Generation High-Content Imaging Capability

Advertise

SAN RAMON, Calif. , Nov. 29, 2011 /PRNewswire/ -- Odyssey Thera, Inc., a technology provider focused on deciphering biologically-relevant pathways in human cells, announced today that it has installed the IN Cell Analyzer 6000, a laser-based confocal imaging platform from GE Healthcare, to advance the world's largest high-content assay capability. Odyssey Thera applies a systems biology approach to advance knowledge of the complex cellular networks responsible for biologically–relevant

Read more ...


Advertise

No comments:

Post a Comment

Related Posts Plugin for WordPress, Blogger...